Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

shareholders$
28.0$
94.8$
97.3$
260.9Plus:Interest expense54.612.7116.781.8Interest income(1.2)(0.5)(2.5)(2.1)Provision for income taxes88.261.5146.8196.9Depreciation (includes accelerated depreciation)36.821.397.593.6Amortization(1)148.4151.5481.9355.5EBITDA354.8341.3937.7986.6Adjusted for:Global supply chain initiative8.40.214.411.0Acquisition and licensing charges77.814.9294.137.7Non-cash impairment charges29.918.7149.544.3Non-recurring (gains) losses(119.3)(0.9)(134.6)(13.2)Legal settlements27.35.087.75.0Accretion (income) expense-(0.1)0.4(0.3)Share-based compensation14.114.348.739.8Adjusted EBITDA$
393.0$
393.4$
,397.9$
,110.9(1) Includes amortization of excess purchase price on equity method investment.The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2013 to non-GAAP net income and non-GAAP earnings per diluted share:

 Table 6Actavis, Inc.Reconciliation Table - Forecasted Non-GAAP Earnings Per Diluted Share(Unaudited; in millions except per share amounts)Forecast for Twelve Months
Ending December 31, 2013LowHighGAAP to Non-GAAP net income calculationGAAP net income$
440$
490Adjusted for:Amortization 625630Global supply chain initiative3535Acquisition and licensing charges 150150Interest accretion on contingent liability 77Non-cash impairment charges Non-recurring (gains) losses Income taxes on items above(222)(224)Adjusted Non-GAAP net income1,0351,088Diluted earnings per shareDiluted earnings per share - GAAP $
3.27$
3.65Diluted earnings per share - Non-GAAP$
7.70$
8.10Diluted weighted average common shares outstanding*134.4134.4*Includes the maximum of 5.5 million shares potentially issuable to the former shareholders of the Actavis Group, subject to final determination of the legacy Actavis business' 2012 Cash EBITDA as calculated in the Actavis acquisit
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... 30, 2015  Medimetriks Pharmaceuticals, Inc. announced today ... III clinical study for Ozenoxacin, a novel bactericidal ... the exclusive U.S. rights to Ozenoxacin 1% cream.  ... 44 centers with an emphasis on U.S. patients, ... months and older with a clinical diagnosis of ...
(Date:7/30/2015)... FRANCISCO , July 30, 2015 ... market is expected to reach USD 23.01 million ... View Research, Inc. Growing base of geriatric population, increasing ... infections, and rising level of awareness among target customer ... rendering drivers over the forecast period. According to estimates ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
... Cloud-based Veeva CRM Now Deployed in Over 20 European ... Customer Summit kicking off this morning in Philadelphia, Veeva Systems ... Since Veeva,s official expansion into Europe in April 2010, the ... than 35 life sciences companies across 20+ different European markets. ...
... AB (OMX: MVIR), a research-based specialty pharmaceutical company focused ... Henric Juserius to be the new head of the ... for Medivir,s pharmaceutical marketing and sales, will join the ... the management team. Henric Juserius has a ...
Cached Medicine Technology:Veeva Systems Announces Dramatic Growth in Europe 2Veeva Systems Announces Dramatic Growth in Europe 3Veeva Systems Announces Dramatic Growth in Europe 4New Executive Vice President Commercial Appointed 2
(Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased to ... Q-Suite 5.9. Q-Suite is their flagship contact center ACD system for Asterisk-based call ... display logic shows the script components to the agent only when wanted, and allows ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... to release a newly redesigned website at Healthpointe.net. The new website will feature ... , The redesign serves to provide smoother interactions between patients and the ...
(Date:7/31/2015)... ... ... According to WFLA on July 16th, Sarasota has seen at ... Thricefold deaths have held steady over the last “couple of months” according to WFLA. ... was spurred by the crackdown of prescription painkillers. Many users who were addicted to ...
(Date:7/31/2015)... Michigan (PRWEB) , ... July 31, 2015 , ... ... baby at Beaumont Hospital's Karmanos Center for Natural Birth . The ... looking for a safe natural childbirth experience. With nurses and caregivers that are ...
(Date:7/31/2015)... ... 2015 , ... EB Medicine, leading publisher of clinical journals, ... to announce that it has partnered with AgileMD to release Pediatric Emergency ... Android smartphones and tablets. , “The April 2015 launch of our flagship ...
Breaking Medicine News(10 mins):Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:Healthpointe Announces Newly Redesigned Website 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3
... taking antioxidants during pregnancy may prevent birth defects in ... mice // were exposed to ethanol and also given ... malformations in the offspring. Ethanol is the intoxicating agent ... alcoholics isn’t the best, people who are alcoholic by ...
... disease may be able to stop or even slightly ... a surgical procedure to implant // embryonic cells into ... dopamine, a neurochemical that helps control movement. People with ... movement problems common in people with the condition. ...
... HAART, the cytomegalovirus was a major problem for AIDS ... and led to faster progression of the disease and ... status in about 375 people infected with HIV using ... years, noting new cases of CMV disease, development of ...
... million men in the United States suffer from erectile ... for men. With exercise and weight loss // , ... improve their sexual function say researchers. ,Researchers, conducted ... losing weight and an increase in physical activity, would ...
... than 40,000 new cases of head and neck cancer are ... annually.// Researchers say there are about 500,000 new cases worldwide ... in a new study say they are disabled by their ... were observed , of the 348 patients, 52 percent were ...
... new study shows dogs may be able to anticipate ... from the dogs in this study was // ... activity, whimpering, and “protective" behavior without aggression. In previous ... abort or even prevent their seizures. Some breeds ...
Cached Medicine News:
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 3.5V halogen source....
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 2.5V halogen source....
All metal construction with fiber optic illumination. Large diameter viewing port, insufflation port, and swivelling airtight window....
Medicine Products: